HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrent FBN1 mutation (R62C) in a Chinese family with isolated ectopia lentis.

AbstractPURPOSE:
To examine the fibrillin-1 (FBN1) gene for mutations in members of a Chinese family with isolated ectopia lentis.
DESIGN:
Clinically relevant laboratory investigation.
METHODS:
Family members underwent clinical examinations. Genomic DNA was extracted from leukocytes of peripheral blood from the available members and 100 controls for mutation analysis. The 65 exons of FBN1 were amplified by polymerase chain reaction and screened for mutations by a combination of denaturing high-performance liquid chromatography analysis and direct DNA sequencing.
RESULTS:
A mutation, c.184C-->T in exon 2 of FBN1, which results in substitution of arginine by cysteine at position 62 of the fibrillin-1 protein (p.R62C) in all affected family members but in none of the unaffected individuals.
CONCLUSIONS:
A recurrent mutation of FBN1 gene resulted in an arginine-to-cysteine residue (p.R62C), is responsible for the patients with isolated ectopia lentis in a Chinese family.
AuthorsRui Yu, Zheng Lai, Wei Zhou, Dong-Dong Ti, Xian-Ning Zhang
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 141 Issue 6 Pg. 1136-8 (Jun 2006) ISSN: 0002-9394 [Print] United States
PMID16765689 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FBN1 protein, human
  • Fibrillin-1
  • Fibrillins
  • Microfilament Proteins
Topics
  • Adult
  • Asian People (genetics)
  • China (epidemiology)
  • Chromatography, High Pressure Liquid
  • Ectopia Lentis (ethnology, genetics)
  • Exons (genetics)
  • Female
  • Fibrillin-1
  • Fibrillins
  • Humans
  • Male
  • Microfilament Proteins (genetics)
  • Pedigree
  • Point Mutation
  • Polymerase Chain Reaction
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: